TotalMarketCap

CervoMed

CRVONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$22.679 M

$1.50 -3.85%

Close of 6 Nov 2026

As of 6 Nov 2026, CervoMed (CRVO) has a market capitalization of $22.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.01M

#3303 by revenue

Earnings

-$27.0M

Loss-making

Shares outstanding

15,128,540

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #376China PharmaCPHI$23.5M
  2. #377Mira PharmaceuticalsMIRA$23.0M
  3. #378CervoMedCRVO$22.7M
  4. #379Filana TherapeuticsFLNA$21.7M
  5. #380IGC PharmaIGC$21.6M

What if CervoMed were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,867,630

Per share 1,245,087× higher

Bitcoin $1.53T

$101,054.19

Per share 67,369× higher

Apple $5.02T

$331,751.49

Per share 221,168× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for CervoMed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.